The "first humanoid robot stock" listed in Hong Kong, UBTech (09880.HK), has delivered an annual report card that far exceeded market expectations. In 2025, the company's full-size embodied AI humanoid robot business revenue skyrocketed by over 2,200% year-over-year, with sales surpassing one thousand units, making it the only company globally to achieve annual deliveries at this scale. This stellar performance ignited investor enthusiasm, with the company's stock price soaring nearly 20% the day after the earnings release.
According to UBTech's full-year 2025 results report released on March 31, the company's total annual revenue reached CNY 2 billion (approximately $291.2 million), a year-over-year increase of 53.3%. The most striking figure came from its intelligent humanoid robot products and solutions business, which has become the company's largest revenue source, accounting for a substantial 41% of total revenue.
Specifically, full-size embodied AI humanoid robots (non-remote-controlled, non-toy, height over 160cm) generated revenue of CNY 820 million (approximately $119.3 million) in 2025, a staggering increase of 2,203.7% year-over-year. Sales volume reached 1,079 units, a growth of over 35,800% compared to the previous year. Based on this, the estimated average selling price for this product line is approximately CNY 760,000 (approximately $110,593) per unit. Additionally, sales of non-full-size, non-embodied AI humanoid robots (including remote-controlled, pre-programmed, and toy categories) totaled 12,759 units.
| Key Financial & Operational Metrics | 2025 Data | Year-over-Year Change |
| --- | --- | --- |
| Total Revenue | CNY 2 billion (approximately $291.2M) | +53.3% |
| Full-Size Humanoid Robot Revenue | CNY 820 million (approximately $119.3M) | +2203.7% |
| Full-Size Humanoid Robot Sales Volume | 1,079 units | +35866.7% |
| Gross Margin | 37.7% | +9.0 percentage points |
| Net Loss | CNY 789.8 million (approximately $114.9M) | Narrowed YoY |
| R&D Investment | Over CNY 500 million (approximately $72.8M) | 25.4% of Revenue |
_Note: Data sourced from UBTech's 2025 Annual Results Report._
The report indicates that the company's overall revenue growth was almost entirely driven by the single business line of humanoid robots. Revenue from the "Other Intelligent Robot Products and Solutions" business, its second-largest revenue source, declined, while revenue from the third-largest source, "Other Intelligent Hardware Equipment," saw only modest growth.
In terms of profitability, UBTech's gross profit for 2025 was CNY 754 million (approximately $109.7 million), a year-over-year increase of 101.6%. The gross margin significantly improved from 28.7% in 2024 to 37.7%, a gain of 9 percentage points. The company's net loss was CNY 789.8 million (approximately $114.9 million), narrowing compared to the previous year. In a subsequent research report, Citigroup noted that UBTech's 37.7% gross margin exceeded the bank's forecast of 30.1% and the market consensus of 31.3%. The margin improvement was primarily attributed to the high-margin humanoid robot business, which boasts a gross margin as high as 54.6%.
Industrial Deployment Emerges as Core Driver
Behind the explosive revenue growth is the scaled deployment of products in industrial manufacturing settings. According to the annual report, over 80% of the 1,079 delivered full-size humanoid robots were deployed in industrial scenarios. The Walker S series of industrial humanoid robots have been deployed in batches across sectors including automotive manufacturing, smart logistics, 3C electronics manufacturing, and semiconductor manufacturing, primarily handling specific tasks such as material handling, sorting, and quality inspection. The customer portfolio includes several Fortune Global 500 companies.
During an earnings conference call on April 1, UBTech's management forecasted that the company's gross margin could further improve to a range of 40% to 43% in 2026. The company stated that subsequent funding will be primarily directed towards the embodied AI field. As of the end of 2025, UBTech held cash and cash equivalents of CNY 4.92 billion (approximately $715.9 million), providing ample support for sustained R&D. In 2025, the company's R&D investment exceeded CNY 500 million (approximately $72.8 million), accounting for 25.4% of revenue. Over the past four years, cumulative R&D investment has reached a total of CNY 1.9 billion (approximately $276.5 million).
Industry Context and Market Reaction
Founded in 2012, UBTech formally entered large humanoid robot R&D in 2016. The company listed on the Hong Kong Stock Exchange in December 2023, becoming the "first humanoid robot stock." Shortly after its IPO, its market capitalization once surpassed HK$130 billion (approximately $16.6 billion), but later experienced a significant correction due to factors such as financial disclosures and shareholder减持, with its market cap falling to near HK$20 billion (approximately $2.6 billion) at its lowest point.
The strong performance in this earnings report is seen as a critical turning point for the company's development. Citigroup reiterated its "Buy" rating on UBTech in its report, setting a target price of HK$155, citing the company's "first-mover advantage in the humanoid robot industry." The report anticipated a positive market reaction to the better-than-expected results.
According to the latest report from market research firm IDC, global humanoid robot shipments in 2025 approached 18,000 units, a year-over-year increase of 508%, with a market size of approximately $440 million. Applications are primarily in entertainment/commercial performances, scientific research/education, and data collection. UBTech is a leader in global shipments within this field.
Impact Analysis and Future Outlook
UBTech's performance surge marks a significant shift for the humanoid robot industry, accelerating from the "proof-of-concept" and "prototype demonstration" phase towards a new era of "value realization" and "scaled commercial deployment." Industry analysis points out that the competitive focus has shifted from比拼运动控制的"小脑" (cerebellum for motor control) to integrating perception, decision-making, and execution through an "embodied AI brain," alongside capabilities for mass production and deployment in real-world scenarios.
Market sources indicate that global tech leaders like Tesla also plan to achieve mass production of its Optimus humanoid robot via dedicated production lines by the end of 2026, focusing on industrial and commercial fields. This suggests that industrial scenarios have become the core battleground targeted by major humanoid robot companies worldwide.
However, challenges persist. Some analysts note that UBTech's high revenue growth rate is partly due to a low base in the previous year, and the sustainability of the company's overall revenue growth momentum remains to be seen. As the humanoid robot market enters a淘汰赛 phase with intensifying competition, market demands on companies' profitability and commercialization pathways will increase. Balancing substantial R&D investment with profitability pressure and exploring more stable, diversified business models will be a long-term challenge facing all humanoid robot companies, including UBTech.
Currently, the humanoid robot赛道 in China is already crowded. By the end of 2025, there were over 150 related companies in China, more than half of which are startups or companies that have跨入局. With continued capital inflow, industry consolidation is expected to intensify, potentially amplifying the technological, data, and production scale advantages of leading companies. By achieving thousand-unit-level deliveries and revenue爆发 in 2025, UBTech has temporarily solidified its market leadership position, but the future competitive landscape remains highly uncertain.
Add to Google Preferred Sources
Once added, BigGo Finance appears first in Google Search Top Stories, so you get the broadest, most up-to-the-minute, and most comprehensive global financial news first.